NovaBridge Biosciences NBP
NASDAQ NBP
$1.26 -0.11 (-7.66%)
As of: Oct 22, 2026 · 2:30 PM EDT

NovaBridge Biosciences (NBP) Change in Other Operating Liabilities (2019 - 2025)

Updated

Analysis

NovaBridge Biosciences (NBP) Change in Other Operating Liabilities (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,167.69 Bn 1,136.27 Bn 19.71 Bn -
2 Johnson & Johnson 648.01 Bn 567.87 Bn 17.30 Bn 2.69 Bn
3 AbbVie 503.52 Bn 476.63 Bn 12.70 Bn -
4 Merck 367.68 Bn 322.06 Bn 12.21 Bn -
5 Novartis Ag 303.32 Bn 267.31 Bn 11.24 Bn -
6 Astrazeneca 269.17 Bn 242.86 Bn 12.86 Bn -
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 195.24 Bn 169.44 Bn 6.22 Bn -
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -112.00 Mn
10 NovaBridge Biosciences 121.14 Mn -674.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 304,000.00
Sep 30, 2025 -206,000.00
Dec 31, 2024 -180,000.00
Sep 30, 2024 -178,000.00
Dec 31, 2020 -451,170.96
Sep 30, 2020 1.34 Mn
Dec 31, 2019 -39,868.50
API Access

NovaBridge Biosciences Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=NBP&period=max&api_key=YOUR_API_KEY